SCHEMBL30224502

SCHEMBL30224502

FC(F)(F)Cn1c(C(F)(F)F)nc2ccc([C@H]3C[C@@H]3c3cc(Cl)nn4ccnc34)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23994348 1.00 — —
SCHEMBL30181703 1.00 — —
SCHEMBL30224401 0.88 AAK1 (0.33) —
SCHEMBL25005878 0.88 AAK1 (0.33) —
SCHEMBL23994758 0.86 — —
SCHEMBL23995220 0.83 THRA (0.32) —
SCHEMBL30224480 0.83 THRA (0.32) —
SCHEMBL23995236 0.83 THRA (0.32) —
SCHEMBL23993691 0.83 EGFR (0.31) —
SCHEMBL30224628 0.83 EGFR (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143194-A1 CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-03-08 — — EP disclosed
Send feedback